Campbell Bradley L 的 Form 4 申報
Amicus Therapeutics, Inc.（FOLD），2023/7/14 申報
- 申報編號
- 0001209191-23-042290
- 申報時間
- 2023/7/14
- 交易日
- 2023/7/12-7/13
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $10.4 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Campbell Bradley LCIK 0001400971 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.50 to $12.51. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
- F2
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.50 to $12.54 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
表 I 有 1 筆交易的價格引用這則附註。
備註
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2022.